Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Martinelli

Showing results (71-80 of 658) with videos related to

Pageof 66
Sort By:
Panminerva Medica|September 22, 2020
Old and new generation proteasome inhibitors in multiple myelomaVittorio Montefusco, Alberto Mussetti, Maria Q Salas, et al.
Haematologica|March 7, 2007
Monitoring BCR-ABL transcript levels by real-time quantitative polymerase chain reaction: a linear regression equation to convert from BCR-ABL/B2M ratio to estimated BCR-ABL/ABL ratioIlaria Iacobucci, Livia Galletti, Marilina Amabile, et al.
Haematologica|September 5, 2007
NPM1 mutations are more stable than FLT3 mutations during the course of disease in patients with acute myeloid leukemiaMichela Palmisano, Tiziana Grafone, Emanuela Ottaviani, et al.
British Journal of Haematology|January 3, 2013
Absence of bi-directional cross-resistance of thrombopoietin receptor agonists in chronic refractory immune thrombocytopenia: possible role of MPL polymorphismsNicola Polverelli, Francesca Palandri, Ilaria Iacobucci, et al.
Hematology Reports|May 28, 2024
Current Therapeutic Sequencing in Chronic Lymphocytic LeukemiaSamir Mouhssine, Nawar Maher, Sreekar Kogila, et al.
Acta Haematologica|May 22, 2004
Fludarabine combination regimen severely affected peripheral blood stem cell mobilizationDaniele Laszlo, Piero Galieni, Donatella Raspadori, et al.
European Journal of Haematology|October 14, 2011
Plerixafor and Filgrastim XM02 (Tevagastrim) as a first line peripheral blood stem cell mobilisation strategy in patients with multiple myeloma and lymphoma candidated to autologous bone marrow transplantationGiovanna Andreola, Aleksandra Babic, Cristina Rabascio, et al.
Leukemia & Lymphoma|March 23, 2010
Dasatinib and nilotinib in imatinib-resistant Philadelphia-positive chronic myelogenous leukemia: a 'head-to-head comparison'Gianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, et al.
Haematologica|March 9, 2004
Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndromeGiovanni Martinelli, Michele Malagola, Emanuela Ottaviani, et al.
Current Hematologic Malignancy Reports|April 25, 2012
Cytogenetic and molecular predictors of outcome in acute lymphocytic leukemia: recent developmentsIlaria Iacobucci, Cristina Papayannidis, Annalisa Lonetti, et al.
Pageof 66

Showing results (71-80 of 658) with videos related to

Sort By:
Pageof 66
Panminerva Medica|September 22, 2020
Old and new generation proteasome inhibitors in multiple myelomaVittorio Montefusco, Alberto Mussetti, Maria Q Salas, et al.
Haematologica|March 7, 2007
Monitoring BCR-ABL transcript levels by real-time quantitative polymerase chain reaction: a linear regression equation to convert from BCR-ABL/B2M ratio to estimated BCR-ABL/ABL ratioIlaria Iacobucci, Livia Galletti, Marilina Amabile, et al.
Haematologica|September 5, 2007
NPM1 mutations are more stable than FLT3 mutations during the course of disease in patients with acute myeloid leukemiaMichela Palmisano, Tiziana Grafone, Emanuela Ottaviani, et al.
British Journal of Haematology|January 3, 2013
Absence of bi-directional cross-resistance of thrombopoietin receptor agonists in chronic refractory immune thrombocytopenia: possible role of MPL polymorphismsNicola Polverelli, Francesca Palandri, Ilaria Iacobucci, et al.
Hematology Reports|May 28, 2024
Current Therapeutic Sequencing in Chronic Lymphocytic LeukemiaSamir Mouhssine, Nawar Maher, Sreekar Kogila, et al.
Acta Haematologica|May 22, 2004
Fludarabine combination regimen severely affected peripheral blood stem cell mobilizationDaniele Laszlo, Piero Galieni, Donatella Raspadori, et al.
European Journal of Haematology|October 14, 2011
Plerixafor and Filgrastim XM02 (Tevagastrim) as a first line peripheral blood stem cell mobilisation strategy in patients with multiple myeloma and lymphoma candidated to autologous bone marrow transplantationGiovanna Andreola, Aleksandra Babic, Cristina Rabascio, et al.
Leukemia & Lymphoma|March 23, 2010
Dasatinib and nilotinib in imatinib-resistant Philadelphia-positive chronic myelogenous leukemia: a 'head-to-head comparison'Gianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, et al.
Haematologica|March 9, 2004
Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndromeGiovanni Martinelli, Michele Malagola, Emanuela Ottaviani, et al.
Current Hematologic Malignancy Reports|April 25, 2012
Cytogenetic and molecular predictors of outcome in acute lymphocytic leukemia: recent developmentsIlaria Iacobucci, Cristina Papayannidis, Annalisa Lonetti, et al.
Pageof 66